Teva Provides Update On Gemzar(R) Litigation

Links shared publicly online about this topic.

  • 1,259
    total visits

Teva Provides Update On Gemzar(R) Litigation

medicalnewstoday.com

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. District Court for the Southern District of Indiana issued a decision yesterday on two patents for Gemzar® (gemcitabi

View full resource at medicalnewstoday.com

Tags: Pharma, Teva Pharmaceutical Industries, Litigation

  • Share

Most Recently Shared on April 7, 2010 at 2:06 am By:

Also Shared By:

medical_tweets medical_tweets

Advertisement